C0876994||Cardiac Toxicity
C0005516||Biomarkers
C0034693||Rats
C0022877||Laboratories
C0184511||improved
C0220901||prognostic
C0876994||cardiac toxicity
C0872152||drug development
C2603343||study
C0011000||reports
C0005516||biomarker kits
C2607850||institutions
C2607850||SRI
C0027046||myocardial degeneration
C1442837||necrosis
C1383860||cardiac hypertrophy
C1144709||natriuretic peptides
C0027481||N-terminal pro-atrial natriuretic peptide
C0027481||N-terminal pro-atrial natriuretic peptide
C0754710||N-terminal pro-brain natriuretic peptide
C0754710||N-terminal pro-brain natriuretic peptide
C0018787||cardiac
C0521324||skeletal
C0041199||troponins
C1305957||cardiac and skeletal troponins
C3538889||cTnT
C0033684||sTnI
C0027108||myosin light chain 3
C0027108||myosin light chain 3
C1721418||fatty acid binding protein 3
C1721418||fatty acid binding protein 3
C0034693||rats
C0026196||minoxidil
C0026196||minoxidil
C0022245||isoproterenol
C0022245||isoproterenol
C0026196||minoxidil
C0018787||heart
C0702240||elevations
C0027481||N-terminal pro-atrial natriuretic peptide
C0754710||N-terminal pro-brain natriuretic peptide
C0442726||detected
C0702240||elevation
C0041199||troponins
C0027108||myosin light chain 3
C1721418||fatty acid binding protein 3
C1513916||no
C0205161||abnormal
C0243095||findings
C0022245||isoproterenol
C1522565||ventricular
C0333361||leukocyte infiltration
C0151654||myocyte fibrosis
C0027540||necrosis
C1144709||natriuretic peptides
C0018787||cardiac
C0041199||troponins
C0027108||myosin light chain 3
C0018799||cardiac insult
C0442726||detecting
C0027061||myocardial
C0010957||tissue damage
C0936012||analyses
C0022877||laboratories
C0005516||biomarkers
C1709631||preclinical studies